We are live on ! Find out more
NVAX icon

Novavax

135 hedge funds and large institutions have $157M invested in Novavax in 2017 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 45 increasing their positions, 33 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

143% more capital inflows, than outflows

Capital inflows: $24M | Capital outflows: $9.9M

36% more repeat investments, than reductions

Existing positions increased: 45 | Existing positions reduced: 33

22% more call options, than puts

Call options by funds: $1.36M | Put options by funds: $1.12M

17% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 12

5% more funds holding

Funds holding: 129 → 135 (+6)

1.22% more ownership

Funds ownership: 39.22% → 40.43% (+1.2%)

Holders
135
Holders Change
+6
Holders Change %
+4.65%
% of All Funds
3.06%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
45
Reduced
33
Closed
12
Calls
$1.36​M
Puts
$1.12​M
Net Calls
+$243​K
Net Calls Change
-⁠$19​K

NVAX Hedge Fund Activity: Q4 2017 in Review

135 of the 4,418 institutional investors tracked by Wall St. Rank reported a position in Novavax (NVAX) for Q4 2017, worth a combined $157M — up 20% from $132M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new NVAX positions and 12 closed out — a net gain of 2 holders — while 45 added to existing stakes and 33 trimmed.

The largest buyer was State Street, adding an estimated $8.33M. The largest seller was Millennium Management, cutting an estimated $3.87M.

  • 135 institutional investors held Novavax (NVAX) as of Q4 2017, up from 129 in Q3 2017.
  • Funds reported $157M of Novavax stock for Q4 2017, up 20% quarter-over-quarter.
  • 14 funds opened new Novavax positions in Q4 2017 and 12 closed out, a net change of +2 holders.
  • The largest Novavax buyer in Q4 2017 was State Street, an estimated $8.33M added.
  • The largest Novavax seller in Q4 2017 was Millennium Management, an estimated $3.87M sold.

Based on aggregated 13F filings for Q4 2017.